Home › Ductal Carcinoma In Situ (DCIS) › Illinois › Chicago
Ductal Carcinoma In Situ (DCIS) clinical trials in Chicago, IL
4 studies for Ductal Carcinoma In Situ (DCIS) are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
RecruitingPhase 2
- University of Chicago Medical Center, Chicago
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RecruitingHealthy volunteers welcome
- University of Chicago, Chicago
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RecruitingPhase 2
- Northwestern University, Chicago
- University of Illinois College of Medicine - Chicago, Chicago
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RecruitingPhase 2
- Northwestern University, Chicago
Ductal Carcinoma In Situ (DCIS) trials in other cities
- Houston, TX5 studies
- New York City, NY5 studies
- Columbus, OH4 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
- Kansas City, KS3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.